This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology Gastric Cancer (Version 2.2020). [Accessed July 7, 2020]. Available at: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.National Comprehensive Cancer Network (NCCN)Clinical Practice Guidelines in Oncology Gastric Cancer (Version 2.2020)[Accessed July 7, 2020]. Available at: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdfSearch in Google Scholar
Strand MS, Lockhart AC, Fields RC. Genetics of gastric cancer. Surg Clin North Am. 2017; 97(2): 345–370.StrandMSLockhartACFieldsRCGenetics of gastric cancerSurg Clin North Am201797234537010.1016/j.suc.2016.11.00928325191Search in Google Scholar
Wang Q, Liu G, Hu C. Molecular classification of gastric adenocarcinoma. Gastroenterology Res. 2019; 12(6): 275–282.WangQLiuGHuCMolecular classification of gastric adenocarcinomaGastroenterology Res201912627528210.14740/gr1187687902931803306Search in Google Scholar
Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012; 6(6): 590–610.JanssonMDLundAHMicroRNA and cancerMol Oncol20126659061010.1016/j.molonc.2012.09.006552835023102669Search in Google Scholar
Price C, Chen J. MicroRNAs in cancer biology and therapy: Current status and perspectives. Genes Dis. 2014; 1(1): 53–63.PriceCChenJMicroRNAs in cancer biology and therapy: Current status and perspectivesGenes Dis201411536310.1016/j.gendis.2014.06.004424981525473652Search in Google Scholar
Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H, et al. DbDEMC 2.0: Updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res. 2017; 45(D1): D812–D818.YangZWuLWangATangWZhaoYZhaoHDbDEMC 2.0: Updated database of differentially expressed miRNAs in human cancersNucleic Acids Res201745D1D812D81810.1093/nar/gkw1079521056027899556Search in Google Scholar
East Carolina University, Greenville, NC, USA. microRNA Cancer Association Database. Published 2020. [Accessed February 18 2019]. Available at: http://mircancer.ecu.edu/index.jsp.East Carolina UniversityGreenville, NC, USAmicroRNA Cancer Association DatabasePublished 2020. [Accessed February 18 2019]. Available at: http://mircancer.ecu.edu/index.jspSearch in Google Scholar
National Center for Biotechnology Information (NCBI). DNA and RNA databases. Published 2019. [Accessed July 7 2020] Available at: https://www.ncbi.nlm.nih.gov/.National Center for Biotechnology Information (NCBI)DNA and RNA databasesPublished 2019. [Accessed July 7 2020] Available at: https://www.ncbi.nlm.nih.gov/Search in Google Scholar
Morata-Tarifa C, Picon-Ruiz M, Griñan-Lison C, Boulaiz H, Perán M, Garcia MA, et al. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity. Sci Rep. 2017; 7: 39782.Morata-TarifaCPicon-RuizMGriñan-LisonCBoulaizHPeránMGarciaMAValidation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneitySci Rep201773978210.1038/srep39782520971328051134Search in Google Scholar
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, et al. MicroRNA-375 is down-regulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010; 70(6): 2339–2349.TsukamotoYNakadaCNoguchiTTanigawaMNguyenLTUchidaTMicroRNA-375 is down-regulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zetaCancer Res20107062339234910.1158/0008-5472.CAN-09-277720215506Search in Google Scholar
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010; 20(7): 784–793.DingLXuYZhangWDengYSiMDuYMiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2Cell Res201020778479310.1038/cr.2010.7920548334Search in Google Scholar
Shen Z-Y, Zhang Z-Z, Liu H, Zhao E-H, Cao H. miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med. 2014; 7(6): 1757–1761.ShenZ-YZhangZ-ZLiuHZhaoE-HCaoHmiR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expressionExp Ther Med2014761757176110.3892/etm.2014.1627404357224926380Search in Google Scholar
Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oz HZ, et al. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014; 105(2): 236–243.SakamotoNNaitoYOueNSentaniKUraokaNOzHZMicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosisCancer Sci2014105223624310.1111/cas.12330431781624283384Search in Google Scholar
Zheng G, Xiong Y, Xu W, Wang Y, Chen F, Wang Z, et al. A two-microRNA signature as a potential biomarker for early gastric cancer. Oncol Lett. 2014; 7(3): 679–684.ZhengGXiongYXuWWangYChenFWangZA two-microRNA signature as a potential biomarker for early gastric cancerOncol Lett20147367968410.3892/ol.2014.1797391989424527072Search in Google Scholar
Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res. 2011; 17(24): 7574–7583.ZhengBLiangLWangCHuangSCaoXZhaRMicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancerClin Cancer Res201117247574758310.1158/1078-0432.CCR-11-171421994419Search in Google Scholar
Tu L, Zhao E, Zhao W, Zhang Z, Tang D, Zhang Y, et al. hsa-miR-376c-3p regulates gastric tumor growth both in vitro and in vivo. BioMed Res Int. 2016; 2016: 1–7.TuLZhaoEZhaoWZhangZTangDZhangYhsa-miR-376c-3p regulates gastric tumor growth both in vitro and in vivoBioMed Res Int201620161710.1155/2016/9604257Search in Google Scholar
Hung P-S, Chen C-Y, Chen W-T, Kuo C-Y, Fang W-L, Huang KH, et al. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLos One. 2017; 12(5): e0177346.HungP-SChenC-YChenW-TKuoC-YFangW-LHuangKHmiR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinomaPLos One2017125e017734610.1371/journal.pone.0177346542364428486502Search in Google Scholar
Yu X, Song H, Xia T, Han S, Xiao B, Luo L, et al. Growth inhibitory effects of three miR-129 family members on gastric cancer. Gene. 2013; 532(1): 87–93.YuXSongHXiaTHanSXiaoBLuoLGrowth inhibitory effects of three miR-129 family members on gastric cancerGene20135321879310.1016/j.gene.2013.09.04824055727Search in Google Scholar
Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, et al. lncRNA-AC130710 targeting by miR-129-5p is up-regulated in gastric cancer and associates with poor prognosis. Tumor Biol. 2014; 35(10): 9701–9706.XuCShaoYXiaTYangYDaiJLuoLlncRNA-AC130710 targeting by miR-129-5p is up-regulated in gastric cancer and associates with poor prognosisTumor Biol201435109701970610.1007/s13277-014-2274-524969565Search in Google Scholar
Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, et al. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother Pharmacol. 2013; 71(5): 1159–1171.WuHHuangMLuMZhuWShuYCaoPRegulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxelCancer Chemother Pharmacol20137151159117110.1007/s00280-013-2108-y23423488Search in Google Scholar
Oh H-K, Tan AL-k, Das K, Ooi C-H, Deng N-T, Tan IB, et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res. 2011; 17(9): 2657–2667.OhH-KTanAL-kDasKOoiC-HDengN-TTanIBGenomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancerClin Cancer Res20111792657266710.1158/1078-0432.CCR-10-315221415212Search in Google Scholar
Geng H, Li K, Pan Q, Tao S, Li C, Zhao H, et al. Identification and expression of several circular RNAs and knockdown of hsa_circ_0005556 exerts oncogenic functions by miR-767-5p in gastric cancer. Med Sci Monit. 2020; 26: e921163.GengHLiKPanQTaoSLiCZhaoHIdentification and expression of several circular RNAs and knockdown of hsa_circ_0005556 exerts oncogenic functions by miR-767-5p in gastric cancerMed Sci Monit202026e92116310.12659/MSM.921163741291932728015Search in Google Scholar
Bradburn S. How to perform the delta-delta Ct method? [Accessed July 7 2020] Available at: https://toptipbio.com/delta-delta-ct-pcr/.BradburnSHow to perform the delta-delta Ct method?[Accessed July 7 2020] Available at: https://toptipbio.com/delta-delta-ct-pcr/Search in Google Scholar
Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York, NY, USA: Springer-Verlag, 2016. Retrieved from https://ggplot2.tidyverse.org.WickhamHggplot2: Elegant Graphics for Data AnalysisNew York, NY, USASpringer-Verlag2016Retrieved from https://ggplot2.tidyverse.org10.1007/978-3-319-24277-4Search in Google Scholar
Brierley J, Gospodarowicz MK, Wittekind CH, Editors. TNM Classification of Malignant Tumours, 8th ed. Oxford, Oxon, UK; John Wiley & Sons, Inc.; 2017.BrierleyJGospodarowiczMKWittekindCHEditors.TNM Classification of Malignant Tumours8th ed.Oxford, Oxon, UKJohn Wiley & Sons, Inc.201710.1002/9780471420194.tnmc26.pub3Search in Google Scholar
Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: A comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020; 39(4): 1179–1203.SextonREAl HallakMNDiabMAzmiASGastric cancer: A comprehensive review of current and future treatment strategiesCancer Metastasis Rev20203941179120310.1007/s10555-020-09925-3768037032894370Search in Google Scholar
Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol. 2018; 24(30): 3313–3329.LinkAKupcinskasJMicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectivesWorld J Gastroenterol201824303313332910.3748/wjg.v24.i30.3313609258330122873Search in Google Scholar
Li Z, Liu Z-M, Xu B-H. A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer. Eur Rev Med Pharmacol Sci. 2018; 22(23): 8281–8287.LiZLiuZ-MXuB-HA meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancerEur Rev Med Pharmacol Sci2018222382818287Search in Google Scholar
Wang Q-X, Zhu Y-Q, Zhang H, Xiao J. Altered miRNA expression in gastric cancer: A systematic review and meta-analysis. Cell Physiol Biochem. 2015; 35(3): 933–944.WangQ-XZhuY-QZhangHXiaoJAltered miRNA expression in gastric cancer: A systematic review and meta-analysisCell Physiol Biochem201535393394410.1159/00036975025633747Search in Google Scholar
Ben-Dayan MM, MacCarthy T, Schlecht NF, Belbin TJ, Childs G, Smith RV, et al. Cancer as the disintegration of robustness: Population-level variance in gene expression identifies key differences between tobacco- and HPV-associated oropharyngeal carcinogenesis. Arch Pathol Lab Med.. 2015; 139(11): 1362–1372.Ben-DayanMMMacCarthyTSchlechtNFBelbinTJChildsGSmithRVCancer as the disintegration of robustness: Population-level variance in gene expression identifies key differences between tobacco- and HPV-associated oropharyngeal carcinogenesisArch Pathol Lab Med.2015139111362137210.5858/arpa.2014-0624-OA569555426132601Search in Google Scholar
Hooten NN, Fitzpatrick M, Wood WH 3rd, De S, Ejiogu N, Zhang Y, et al. Age-related changes in micro-RNA levels in serum. Aging (Albany NY). 2013; 5(10): 725–740.HootenNNFitzpatrickMWoodWH3rdDeSEjioguNZhangYAge-related changes in micro-RNA levels in serumAging (Albany NY)201351072574010.18632/aging.100603383877624088671Search in Google Scholar
Cui S, Zhang K, Li C, Chen J, Pan Y, Feng B, et al. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget. 2016; 7(47): 78009–78028.CuiSZhangKLiCChenJPanYFengBMethylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-AOncotarget2016747780097802810.18632/oncotarget.12870536364027793005Search in Google Scholar
Xu Y, Deng Y, Yan X, Zhou T. Targeting miR-375 in gastric cancer. Expert Opin Ther Targets. 2011; 15(8): 961–972.XuYDengYYanXZhouTTargeting miR-375 in gastric cancerExpert Opin Ther Targets201115896197210.1517/14728222.2011.58123221557705Search in Google Scholar
Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C, et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2011; 15(1): 199–208.BhattiILeeAJamesVHallRILundJNTufarelliCKnockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinomaJ Gastrointest Surg201115119920810.1007/s11605-010-1381-x21088996Search in Google Scholar
Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer. 2010; 127(12): 2870–2878.YuLToddNWXingLXieYZhangHLiuZEarly detection of lung adenocarcinoma in sputum by a panel of microRNA markersInt J Cancer2010127122870287810.1002/ijc.25289354547121351266Search in Google Scholar
Yan X-L, Luo Q-Y, Zhou S-N, Pan W-T, Zhang L, Yang D-J, et al. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer. Clin Res Hepatol Gastroenterol. 2021; 45(5): 101574.YanX-LLuoQ-YZhouS-NPanW-TZhangLYangD-JMicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancerClin Res Hepatol Gastroenterol202145510157410.1016/j.clinre.2020.10.01533272890Search in Google Scholar
Lian S, Park J, Xia Y, Nguyen TT, Joo YE, Kim KK, et al. MicroRNA-375 functions as a tumor-suppressor gene in gastric cancer by targeting Recepteur d’Origine Nantais. Int J Mol Sci. 2016; 17(10): 1633.LianSParkJXiaYNguyenTTJooYEKimKKMicroRNA-375 functions as a tumor-suppressor gene in gastric cancer by targeting Recepteur d’Origine NantaisInt J Mol Sci20161710163310.3390/ijms17101633508566627689991Search in Google Scholar
Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, et al. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021; 12(1): 325.NiHQinHSunCLiuYRuanGGuoQMiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosisStem Cell Res Ther202112132510.1186/s13287-021-02394-7818014634090492Search in Google Scholar
Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014; 140(9): 1451–1456.XiaJGuoXYanJDengKThe role of miR-148a in gastric cancerJ Cancer Res Clin Oncol201414091451145610.1007/s00432-014-1649-824659367Search in Google Scholar
Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, et al. MiR-148a functions as a tumor suppressor by targeting CCKBR via inactivating STAT3 and Akt in human gastric cancer. PLoS One. 2016; 11(8): e0158961.YuBLvXSuLLiJYuYGuQMiR-148a functions as a tumor suppressor by targeting CCKBR via inactivating STAT3 and Akt in human gastric cancerPLoS One2016118e015896110.1371/journal.pone.0158961498259827518872Search in Google Scholar
Mu Y-P, Tang S, Sun W-J, Gao W-M, Wang M, Su X-L. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. Asian Pac J Cancer Prev. 2014; 15(20): 8893–8900.MuY-PTangSSunW-JGaoW-MWangMSuX-LAssociation of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancerAsian Pac J Cancer Prev201415208893890010.7314/APJCP.2014.15.20.8893Search in Google Scholar
Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. MicroRNA-196: Critical roles and clinical applications in development and cancer. J Cell Mol Med. 2011; 15(1): 14–23.ChenCZhangYZhangLWeakleySMYaoQMicroRNA-196: Critical roles and clinical applications in development and cancerJ Cell Mol Med2011151142310.1111/j.1582-4934.2010.01219.x327607621091634Search in Google Scholar
Skrzypski M, Czapiewski P, Goryca K, Jassem E, Wrywicz L, Pawlowski R, et al. Prognostic value of microRNA expression in operable non-small cell lung cancer patients. Br J Cancer. 2014; 110(4): 991–1000.SkrzypskiMCzapiewskiPGorycaKJassemEWrywiczLPawlowskiRPrognostic value of microRNA expression in operable non-small cell lung cancer patientsBr J Cancer20141104991100010.1038/bjc.2013.786392987124448358Search in Google Scholar
Filipska M, Skrzypski M, Czetyrbok K, Stokowy T, Stasilojc G, Supernat A, et al. MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. Lung Cancer. 2018; 118: 111–118.FilipskaMSkrzypskiMCzetyrbokKStokowyTStasilojcGSupernatAMiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinomaLung Cancer201811811111810.1016/j.lungcan.2018.02.00229571988Search in Google Scholar
Loriot A, Van Tongelen A, Blanco J, Klaessens S, Cannuyer J, Van Baren N, et al. A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics. 2014; 9(8): 1163–1171.LoriotAVan TongelenABlancoJKlaessensSCannuyerJVan BarenNA novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumorsEpigenetics2014981163117110.4161/epi.29628416450125089631Search in Google Scholar
Zhang K, Guo L. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression. Gene. 2018; 641: 272–278.ZhangKGuoLMiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expressionGene201864127227810.1016/j.gene.2017.10.05529054757Search in Google Scholar
Feng Y, Zhang L, Wu J, Khadka B, Fang Z, Gu J, et al. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway. J Exp Clin Cancer Res. 2019; 38(1): 54.FengYZhangLWuJKhadkaBFangZGuJCircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathwayJ Exp Clin Cancer Res20193815410.1186/s13046-019-1071-9636448230728056Search in Google Scholar
Liu H, Wu Y, Wang S, Jiang J, Zhang C, Jiang Y, et al. Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p. BMC Cancer. 2019; 19(1): 937.LiuHWuYWangSJiangJZhangCJiangYCirc-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5pBMC Cancer201919193710.1186/s12885-019-6088-0678593431601173Search in Google Scholar
Zhang L, Geng Z, Wan Y, Meng F, Meng X, Wang L. Functional analysis of miR-767-5p during the progression of hepatocellular carcinoma and the clinical relevance of its dysregulation. Histochem Cell Biol. 2020; 154(2): 231–243.ZhangLGengZWanYMengFMengXWangLFunctional analysis of miR-767-5p during the progression of hepatocellular carcinoma and the clinical relevance of its dysregulationHistochem Cell Biol2020154223124310.1007/s00418-020-01878-632333091Search in Google Scholar
Xiang Z, Xu C, Wu G, Liu B, Wu D. CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p. Open Med (Wars). 2019; 14(1): 833–842.XiangZXuCWuGLiuBWuDCircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5pOpen Med (Wars)201914183384210.1515/med-2019-0097688492431844675Search in Google Scholar
Zhang J, Xu S, Xu J, Li Y, Zhang J, Zhang J, et al. miR 767 5p inhibits glioma proliferation and metastasis by targeting SUZ12. Oncol Rep. 2019; 42(1): 55–66.ZhangJXuSXuJLiYZhangJZhangJmiR 767 5p inhibits glioma proliferation and metastasis by targeting SUZ12Oncol Rep2019421556610.3892/or.2019.7156654908731115583Search in Google Scholar